Patents Assigned to BIRDIE PHARMACEUTICALS, INC.
  • Anti-EGFR combinations for treating tumors
    Patent number: 11136397
    Abstract: The present invention relates to therapeutic combinations and methods for treating cancers using combination therapy.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: October 5, 2021
    Assignee: BIRDIE PHARMACEUTICALS, INC.
    Inventor: Lixin Li